Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02428400
What this trial is testing

Safety and Tolerability of TG1050: A Dose-finding Study

Who this might be right for
Chronic Hepatitis B
Transgene 48
Early research (Phase 1)Study completedNCT02558413
What this trial is testing

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 60
Not applicableUnknownNCT05519761
What this trial is testing

A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports

Who this might be right for
VeinousChemotherapyAntibiotics+5 more
Perouse Medical 250
Not applicableEnrolling By InvitationNCT04942886
What this trial is testing

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

Who this might be right for
Hepatitis B ReactivationHematopoietic Stem Cell TransplantationAntiviral Drug+1 more
Seoul St. Mary's Hospital 226
Early research (Phase 1)Study completedNCT06744686
What this trial is testing

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

Who this might be right for
Chronic Hepatitis B
Suzhou HepaThera Biotech Co., Ltd. 56
Testing effectiveness (Phase 2)Study completedNCT00002156
What this trial is testing

Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Ionis Pharmaceuticals, Inc. 194
Not applicableEnded earlyNCT01168856
What this trial is testing

An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 734
Not applicableLooking for participantsNCT05661786
What this trial is testing

Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 4,500
Not applicableNot Yet RecruitingNCT07520123
What this trial is testing

Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 2,000
Testing effectiveness (Phase 2)Study completedNCT05595369
What this trial is testing

RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

Who this might be right for
Long COVIDLong Covid19
Kanecia Obie Zimmerman 963
Large-scale testing (Phase 3)Study completedNCT00001038
What this trial is testing

Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Testing effectiveness (Phase 2)Study completedNCT01371578
What this trial is testing

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 163
Post-approval studies (Phase 4)Study completedNCT00056862
What this trial is testing

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 58
Large-scale testing (Phase 3)Ended earlyNCT00958776
What this trial is testing

Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Who this might be right for
CoughSore ThroatNasal Congestion+3 more
BioCryst Pharmaceuticals 405
Testing effectiveness (Phase 2)Study completedNCT00634959
What this trial is testing

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Who this might be right for
HIV
ViiV Healthcare 37
Post-approval studies (Phase 4)Study completedNCT01320943
What this trial is testing

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 43
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Early research (Phase 1)Study completedNCT00006325
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07145268
What this trial is testing

Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy

Who this might be right for
Liver FibrosesHBV (Hepatitis B Virus)
Tanta University 44
Early research (Phase 1)UnknownNCT05925140
What this trial is testing

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19Hospitalized COVID-19 Patients
Lebanese University 1,000
Next Page